| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |